MétaCan
Menu
← Back to cohort
Record W4408329014 · doi:10.2215/cjn.0000000666

Combination Automated Microfluidics Measurement of Urine C-C Motif Ligand 2, CXC-Motif Chemokine 9, CXC-Motif Chemokine 10, and Vascular Endothelial Growth Factor A for Monitoring Patients with a Kidney Transplant

2025· article· en· W4408329014 on OpenAlexaff
Michael E. Seifert, Alvin T. Kho, Lea Sheward, Nancy Rodig, Sarah Goldberg, David Zurakowski, Roslyn B. Mannon, Vikas R. Dharnidharka, Oriol Bestard, Tom Blydt‐Hansen, David M. Briscoe

Bibliographic record

VenueClinical Journal of the American Society of Nephrology · 2025
Typearticle
Languageen
FieldMedicine
TopicRenal Transplantation Outcomes and Treatments
Canadian institutionsBC Children's Hospital
FundersNational Institute of Diabetes and Digestive and Kidney Diseases
KeywordsMedicineUrinary systemBiomarkerCXCL10CreatinineUrologyInternal medicineCXCL9KidneyAcute kidney injuryChemokineInflammation

Abstract

fetched live from OpenAlex

Key Points Combining urine C-C motif ligand 2, CXC-motif chemokine 9, CXC-motif chemokine 10, and vascular endothelial growth factor A identifies stable transplant recipients without biopsy-proven acute rejection with >75% specificity and 94% negative predictive value. Measuring four urine analytes in combination using an automated platform is highly efficient (<70 minutes) and reproducible across three independent sites. Automated urine analyte measurement provides critical decision support and outperforms eGFR measurements alone for post-transplantation monitoring. Background Recent studies indicate that up to 36% of pediatric and adult kidney transplant recipients with stable serum creatinine levels will have acute rejection detected on surveillance biopsy. The purpose of this study was to develop and validate a risk algorithm for identifying low- and high-risk patients using a novel automated platform that simultaneously measures urinary C-C motif ligand 2 (CCL2), CXC-motif chemokine 9 (CXCL9), CXC-motif chemokine 10 (CXCL10), and vascular endothelial growth factor A (VEGF-A) with high precision. Methods We designed a multicenter observational study to evaluate the performance of urinary CCL2, CXCL9, CXCL10, and VEGF-A in a training set of 517 banked samples collected at the time of surveillance or indication kidney biopsies from both adult and pediatric recipients. Risk algorithms combining all four analytes were developed in the training set and subsequently validated in three laboratory sites in two additional pediatric cohorts ( N =174). Results The automated platform had remarkably high throughput, generating reproducible results in 60–70 minutes. Analysis was initially performed in the training set ( N =517), which included biopsies read as normal ( N =330), acute rejection ( N =92), or borderline rejection ( N =95). We found that each biomarker independently discriminated normal biopsies versus those with acute rejection ( P < 10 −5 ). A risk algorithm using all four biomarkers (score4) had excellent diagnostic performance for acute rejection in both for-cause and surveillance biopsies performed on patients with stable GFRs, outperforming any individual biomarker as well as estimated GFR assessments. Validation assays performed in the two additional pediatric cohorts in three laboratory sites demonstrated a robust correlation of results; score4 retained excellent diagnostic performance (75% specificity and 92% negative predictive value). Conclusions Automated measurements of urine CCL2, CXCL9, CXCL10, and VEGF-A can distinguish kidney transplant recipients at low versus high risk of rejection. We suggest that this assay can advantage clinical decision making in routine post-transplant monitoring because of its low cost, rapid throughput, and operator independence.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.002
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.007

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.002
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0010.000
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.000
Research integrity0.0000.000
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.024
GPT teacher head0.312
Teacher spread0.288 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes1
Has abstractyes

Explore more

Same venueClinical Journal of the American Society of Nephrology→Same topicRenal Transplantation Outcomes and Treatments→French-language works237,207→